Lantern Pharma (LTRN) Tops Q4 EPS by 1c

Lantern Pharma (NASDAQ: LTRN) reported Q4 EPS of ($0.39), $0.01 better than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Lantern Pharma (LTRN) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Goldman starts Talen at buy, sees PJM power tightness boosting earnings
• Accenture tumbles 16% on guidance cut; announces Dragos, runZero, NetRise deals